Vanessa S. Cull

506 total citations
15 papers, 393 citations indexed

About

Vanessa S. Cull is a scholar working on Epidemiology, Immunology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Vanessa S. Cull has authored 15 papers receiving a total of 393 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 7 papers in Immunology and 6 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Vanessa S. Cull's work include Cytomegalovirus and herpesvirus research (7 papers), Herpesvirus Infections and Treatments (6 papers) and Viral Infections and Immunology Research (6 papers). Vanessa S. Cull is often cited by papers focused on Cytomegalovirus and herpesvirus research (7 papers), Herpesvirus Infections and Treatments (6 papers) and Viral Infections and Immunology Research (6 papers). Vanessa S. Cull collaborates with scholars based in Australia, United States and Germany. Vanessa S. Cull's co-authors include Cassandra M. James, Emmalene J. Bartlett, Peta A. Tilbrook, Jason C. Lenzo, Peter Härle, Daniel J.J. Carr, Geoffrey Shellam, DeLisa Fairweather, Bryan Williams and Robert H. Silverman and has published in prestigious journals such as Blood, Oncogene and Journal of Virology.

In The Last Decade

Vanessa S. Cull

15 papers receiving 390 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Vanessa S. Cull Australia	11	227	146	105	83	79	15	393
Albrecht Werner Germany	8	144 0.6×	80 0.5×	109 1.0×	30 0.4×	46 0.6×	12	395
G Clements United Kingdom	5	139 0.6×	158 1.1×	248 2.4×	22 0.3×	77 1.0×	6	446
Sarah Van Scoy United States	6	286 1.3×	92 0.6×	183 1.7×	24 0.3×	188 2.4×	6	497
P. H. Hofschneider Germany	8	73 0.3×	129 0.9×	60 0.6×	142 1.7×	115 1.5×	14	385
Richard D. Schneiderman United States	9	121 0.5×	177 1.2×	32 0.3×	29 0.3×	163 2.1×	11	458
Kerri R. Thomas United States	6	587 2.6×	46 0.3×	140 1.3×	27 0.3×	104 1.3×	10	688
Anja M. Mehl United Kingdom	8	233 1.0×	167 1.1×	238 2.3×	8 0.1×	73 0.9×	11	482
Carole Dantin Switzerland	11	328 1.4×	68 0.5×	144 1.4×	14 0.2×	86 1.1×	18	490
Lyda M. Osorio Sweden	11	265 1.2×	109 0.7×	72 0.7×	16 0.2×	212 2.7×	15	565
Jeff Hooley United States	7	280 1.2×	59 0.4×	71 0.7×	11 0.1×	124 1.6×	15	455

Countries citing papers authored by Vanessa S. Cull

Since Specialization

Citations

This map shows the geographic impact of Vanessa S. Cull's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vanessa S. Cull with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vanessa S. Cull more than expected).

Fields of papers citing papers by Vanessa S. Cull

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vanessa S. Cull. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vanessa S. Cull. The network helps show where Vanessa S. Cull may publish in the future.

Co-authorship network of co-authors of Vanessa S. Cull

This figure shows the co-authorship network connecting the top 25 collaborators of Vanessa S. Cull. A scholar is included among the top collaborators of Vanessa S. Cull based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vanessa S. Cull. Vanessa S. Cull is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Bartlett, Emmalene J., et al.. (2004). Type I IFN‐β gene therapy suppresses cardiac CD8⁺ T‐cell infiltration during autoimmune myocarditis. Immunology and Cell Biology. 82(2). 119–126. 19 indexed citations

Lenzo, Jason C., et al.. (2003). Cytokine expression in murine cytomegalovirus-induced myocarditis: modulation with interferon-α therapy. Cellular Immunology. 223(1). 77–86. 14 indexed citations

Sarna, Mohinder, Evan Ingley, Samantha J. Busfield, et al.. (2003). Differential regulation of SOCS genes in normal and transformed erythroid cells. Oncogene. 22(21). 3221–3230. 26 indexed citations

Bartlett, Emmalene J., et al.. (2003). Optimization of naked DNA delivery for interferon subtype immunotherapy in cytomegalovirus infection. Biological Procedures Online. 5(1). 43–52. 4 indexed citations

Cull, Vanessa S., et al.. (2003). Type I interferon differential therapy for erythroleukemia: specificity of STAT activation. Blood. 101(7). 2727–2735. 58 indexed citations

Härle, Peter, et al.. (2002). Transient transfection of mouse fibroblasts with type I interferon transgenes provides various degrees of protection against herpes simplex virus infection. Antiviral Research. 56(1). 39–49. 22 indexed citations

Cull, Vanessa S., et al.. (2002). Coimmunisation with type I IFN genes enhances protective immunity against cytomegalovirus and myocarditis in gB DNA-vaccinated mice. Gene Therapy. 9(20). 1369–1378. 35 indexed citations

Lenzo, Jason C., DeLisa Fairweather, Vanessa S. Cull, Geoffrey Shellam, & Cassandra M. James. (2002). Characterisation of Murine Cytomegalovirus Myocarditis: Cellular Infiltration of the Heart and Virus Persistence. Journal of Molecular and Cellular Cardiology. 34(6). 629–640. 47 indexed citations

Bartlett, Emmalene J., et al.. (2002). Synergy of type I interferon‐A6 and interferon‐B naked DNA immunotherapy for cytomegalovirus infection. Immunology and Cell Biology. 80(5). 425–435. 8 indexed citations

10.

Cull, Vanessa S., Emmalene J. Bartlett, & Cassandra M. James. (2002). Type I interferon gene therapy protects against cytomegalovirus‐induced myocarditis. Immunology. 106(3). 428–437. 37 indexed citations

11.

Härle, Peter, Vanessa S. Cull, Martin‐Paul Agbaga, et al.. (2002). Differential Effect of Murine Alpha/Beta Interferon Transgenes on Antagonization of Herpes Simplex Virus Type 1 Replication. Journal of Virology. 76(13). 6558–6567. 55 indexed citations

12.

Tilbrook, Peta A., Gene A. Palmer, David McCarthy, et al.. (2001). Maturation of erythroid cells and erythroleukemia development are affected by the kinase activity of Lyn.. PubMed. 61(6). 2453–8. 45 indexed citations

13.

Cull, Vanessa S., Peta A. Tilbrook, David Chappell, et al.. (2000). Dominant action of mutated erythropoietin receptors on differentiation in vitro and erythroleukemia development in vivo. Oncogene. 19(7). 953–960. 7 indexed citations

14.

Callus, Bernard A., et al.. (1995). Amiloride Suppresses Erythropoietin-Induced Proliferation and MAP Kinase, but Potentiates Differentiation of J2E Cells. Experimental Cell Research. 219(1). 39–46. 13 indexed citations

15.

Warren-Perry, Margaret, et al.. (1993). Restriction fragment length polymorphisms of the human aldose reductase gene: a preliminary report. Diabetes Research and Clinical Practice. 20(2). 165–168. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact